333 related articles for article (PubMed ID: 19680295)
1. Individualized therapy in non-small-cell lung cancer: future versus current clinical practice.
Pérez-Soler R
Oncogene; 2009 Aug; 28 Suppl 1():S38-45. PubMed ID: 19680295
[TBL] [Abstract][Full Text] [Related]
2. Personalized medicine in oncology: tailoring the right drug to the right patient.
Jiang Y; Wang M
Biomark Med; 2010 Aug; 4(4):523-33. PubMed ID: 20701441
[TBL] [Abstract][Full Text] [Related]
3. The role of genetic testing in the prediction of response to EGFR inhibitors in NSCLC.
Hirsch FR
Oncogene; 2009 Aug; 28 Suppl 1():S1-3. PubMed ID: 19680291
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting.
Eberhard DA; Giaccone G; Johnson BE;
J Clin Oncol; 2008 Feb; 26(6):983-94. PubMed ID: 18281673
[TBL] [Abstract][Full Text] [Related]
5. Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors.
John T; Liu G; Tsao MS
Oncogene; 2009 Aug; 28 Suppl 1():S14-23. PubMed ID: 19680292
[TBL] [Abstract][Full Text] [Related]
6. New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.
Crawford J
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S78-86. PubMed ID: 19795580
[TBL] [Abstract][Full Text] [Related]
7. Molecular predictors of chemotherapy response in non-small-cell lung cancer.
Gray J; Simon G; Bepler G
Expert Rev Anticancer Ther; 2007 Apr; 7(4):545-9. PubMed ID: 17428174
[TBL] [Abstract][Full Text] [Related]
8. Integrating new targeted agents into the treatment of non-small-cell lung cancer.
Thatcher N
Lung Cancer; 2006 Dec; 54 Suppl 2():S25-31. PubMed ID: 17056150
[TBL] [Abstract][Full Text] [Related]
9. Novel targeted therapies for non-small cell lung cancer.
Smith PW; Denlinger CE; Jones DR
Thorac Surg Clin; 2006 Nov; 16(4):353-66. PubMed ID: 17240823
[TBL] [Abstract][Full Text] [Related]
10. Molecular markers in the treatment of metastatic colorectal cancer.
Wilson PM; Labonte MJ; Lenz HJ
Cancer J; 2010; 16(3):262-72. PubMed ID: 20526105
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of non-small-cell lung cancer.
Lacroix L; Commo F; Soria JC
Expert Rev Mol Diagn; 2008 Mar; 8(2):167-78. PubMed ID: 18366303
[TBL] [Abstract][Full Text] [Related]
12. The biology of non-small-cell lung cancer: identifying new targets for rational therapy.
Rosell R; Felip E; Garcia-Campelo R; Balaña C
Lung Cancer; 2004 Nov; 46(2):135-48. PubMed ID: 15474661
[TBL] [Abstract][Full Text] [Related]
13. Shortcomings of current therapies for non-small-cell lung cancer: unmet medical needs.
Burris HA
Oncogene; 2009 Aug; 28 Suppl 1():S4-13. PubMed ID: 19680296
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of DNA repair and related pathways: significance in non-small cell lung cancer.
Rothschild SI; Gautschi O; Lara PN; Mack PC; Gandara DR
Curr Opin Oncol; 2011 Mar; 23(2):150-7. PubMed ID: 21119513
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor biomarkers in non-small-cell lung cancer: a riddle, wrapped in a mystery, inside an enigma.
Shepherd FA; Tsao MS
J Clin Oncol; 2010 Feb; 28(6):903-5. PubMed ID: 20100955
[No Abstract] [Full Text] [Related]
16. Evolution of therapy decision-making process for advanced non-small cell lung cancer.
Gebbia V; Mancuso G; Lombardi L; Maiello E
Oncology; 2009; 77 Suppl 1():97-102. PubMed ID: 20130437
[TBL] [Abstract][Full Text] [Related]
17. Genomic medicine in non-small cell lung cancer: paving the path to personalized care.
Sriram KB; Larsen JE; Yang IA; Bowman RV; Fong KM
Respirology; 2011 Feb; 16(2):257-63. PubMed ID: 21044232
[TBL] [Abstract][Full Text] [Related]
18. Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.
Tomaszek SC; Huebner M; Wigle DA
Expert Rev Respir Med; 2010 Aug; 4(4):499-508. PubMed ID: 20658911
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics in non-small-cell lung cancer chemotherapy.
Danesi R; Pasqualetti G; Giovannetti E; Crea F; Altavilla G; Del Tacca M; Rosell R
Adv Drug Deliv Rev; 2009 May; 61(5):408-17. PubMed ID: 19292993
[TBL] [Abstract][Full Text] [Related]
20. Advances in genomic and proteomic studies of non-small-cell lung cancer: clinical and translational research perspective.
Dziadziuszko R; Hirsch FR
Clin Lung Cancer; 2008 Mar; 9(2):78-84. PubMed ID: 18501093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
